19. Pro Forma Financials for Acquisition of Canterbury and Hygeia (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cost of revenues	$ 0	$ 235,803
Gross profit	71,667	138,739
Operating expenses
General, administrative, research and development	2,008,118	4,570,161
Impairment of intangible assets	1,935,621	1,423,844
Warrants, options and stock	4,228,317	3,643,662
Fair value of common stock exchanged for warrants	3,069,792	0
Legal and professional services	1,071,392	2,128,898
Depreciation and amortization	675,757	164,043
Total operating expenses	12,988,997	11,930,608
Loss from operations	(12,917,330)	(11,791,869)
Other (income)/expenses
(Gain)/loss on adjustments to fair value of derivative liability	(8,980,077)	(6,907,748)
Gain on extinguishment of derivative liability	(1,635,967)	0
Other (income)/expense	(71,631)	379,188
Interest expense	228,294	167,894
Total other income	(10,459,381)	(4,942,054)
Net loss	(2,457,949)	(6,849,815)
Net loss attributed to non-controlling interests	(6,401)	(19,079)
Net loss attributed to RestorGenex Corporation	(2,464,350)	(6,868,894)
Preferred dividends	$ 171,625	$ 497,167
Net loss attributable to RestorGenex Corporation common shareholders	(2,635,975)	(7,366,061)
Basic and diluted loss per share	$ (1.00)	$ (8.16)
RestorGenex
Revenues	71,667
Cost of revenues	0
Gross profit	71,667
Operating expenses
General, administrative, research and development	2,008,118
Impairment of intangible assets	1,935,621
Warrants, options and stock	4,228,317
Fair value of common stock exchanged for warrants	3,069,792
Legal and professional services	1,071,392
Depreciation and amortization	675,757
Total operating expenses	12,988,997
Other (income)/expenses
(Gain)/loss on adjustments to fair value of derivative liability	(8,980,077)
Gain on extinguishment of derivative liability	(1,183,093)
Other (income)/expense	(524,505)
Interest expense	228,294
Total other income	(10,459,381)
Net loss	(2,457,949)
Net loss attributed to non-controlling interests	(6,401)
Net loss attributed to RestorGenex Corporation	(2,464,350)
Preferred dividends	$ 171,625
Net loss attributable to RestorGenex Corporation common shareholders	(2,635,975)
Basic and diluted loss per share	$ (1.00)
Basic and fully-diluted weighted average shares outstanding	2,646,603
Pro Forma Adjustments for Canterbury and Hygeia (b)
Revenues	127,167
Cost of revenues	89,387
Gross profit	37,780
Operating expenses
General, administrative, research and development	265,260
Impairment of intangible assets	0
Warrants, options and stock	0
Fair value of common stock exchanged for warrants	0
Legal and professional services	326,646
Depreciation and amortization	14,781
Total operating expenses	606,687
Other (income)/expenses
(Gain)/loss on adjustments to fair value of derivative liability	0
Gain on extinguishment of derivative liability	0
Other (income)/expense	0
Interest expense	20,267
Total other income	20,267
Net loss	(589,174)
Net loss attributed to non-controlling interests	0
Net loss attributed to RestorGenex Corporation	(589,174)
Preferred dividends	$ 0
Net loss attributable to RestorGenex Corporation common shareholders	(589,174)
Other Pro Forma Adjustments
Revenues	0
Cost of revenues	0
Gross profit	0
Operating expenses
General, administrative, research and development	503,732
Impairment of intangible assets	0
Warrants, options and stock	0
Fair value of common stock exchanged for warrants	0
Legal and professional services	0
Depreciation and amortization	659,958
Total operating expenses	1,163,690
Other (income)/expenses
(Gain)/loss on adjustments to fair value of derivative liability	0
Gain on extinguishment of derivative liability	0
Other (income)/expense	0
Interest expense	0
Total other income	0
Net loss	(1,163,690)
Net loss attributed to non-controlling interests	0
Net loss attributed to RestorGenex Corporation	(1,163,690)
Preferred dividends	$ 0
Net loss attributable to RestorGenex Corporation common shareholders	(1,163,690)
Basic and fully-diluted weighted average shares outstanding	1,014,623
Pro Forma Combined
Revenues	198,834
Cost of revenues	89,387
Gross profit	109,447
Operating expenses
General, administrative, research and development	2,777,110
Impairment of intangible assets	1,935,621
Warrants, options and stock	4,228,317
Fair value of common stock exchanged for warrants	3,069,792
Legal and professional services	1,398,038
Depreciation and amortization	1,350,496
Total operating expenses	14,759,374
Other (income)/expenses
(Gain)/loss on adjustments to fair value of derivative liability	(8,980,077)
Gain on extinguishment of derivative liability	(1,183,093)
Other (income)/expense	(524,505)
Interest expense	248,561
Total other income	(10,439,114)
Net loss	(4,210,813)
Net loss attributed to non-controlling interests	(6,401)
Net loss attributed to RestorGenex Corporation	(4,217,214)
Preferred dividends	$ 171,625
Net loss attributable to RestorGenex Corporation common shareholders	$ (4,388,839)
Basic and diluted loss per share	$ (1.20)
Basic and fully-diluted weighted average shares outstanding	3,661,226